Search E-Book

Showing posts with label Pharmacopeia. Show all posts
Showing posts with label Pharmacopeia. Show all posts

Homoeopathic Pharmacopoeia of India

 


The Government of India was pleased to constitute the Homoeopathic Pharmacopoeia Committee vide their letter No. F. 23-2/62-ISM, dated the 22nd September, 1962. The term of the Committee initially was three years.

Subsequently it was extended from time to time. The functions of the Committee are given below:

(i) to prepare a Pharmacopoeia of Homoeopathic drugs, whose therapeutic usefulness has been proved, on the lines of the American, German and British Pharmacopoeia;

(ii) to lay down principles and standards for the preparation of homoeopathic drugs;

(iii) to lay down tests for identity, quality and purity; and

(iv) such other matter as are incidental and necessary for the preparation of a Homoeopathic pharmacopoeia.

So far the Committee held twelve meetings. After these deliberations, the Committee finalized the First Volume of the Homoeopathic Pharmacopoeia of India. The First Volume consists of:

(i) Preface,

(ii) Introduction,

(iii) Historical,

(iv) General Notices,

(v) Abbreviations, 

(vi) Monographs (180); and 

(vii) Appendices

(I to XIX).

The First Volume of the Homoeopathic Pharmacopoeia of India is presented herewith to the Government of India.

Download Here

USP 2025 pdf free download (United State Pharmacopeia 48 - NF 43)

 


The United States Pharmacopeia and NF (FORMULARY National) are two separate compendia that have been combined to create USP 2025 pdf (United States Pharmacopeia 48-NF 43). It includes guidelines for medications, biologicals, chemical preparation, dosage forms, excipients, medical equipment, food supplements, and other treatments. For medications made and sold in the US, the Food and Drug Administration may impose the most recent version of the USPNF standard, which is regarded as official by USP. You may easily download pdf or learn online for free easily. Additionally, you can obtain the most recent version of the USP 2025 pdf (United States Pharmacopeia 48-NF 43).

USP 2025 pdf Monographs

The names, definitions, specifications, and other regulations pertaining to labeling, storage, and packaging are represented by monographs in pharmacopeia. In order to assist guarantee the identity, strength, quality, and purity of items, specifications include tests, processes, and acceptance criteria. Section 5, Monograph Components, contains general requirements for each monograph pieces.

Because monographs may not provide standards for all relevant characteristics, some official substances can comply with USP or NF standards but different in connection with non-standard nature.

which is relevant to its use in specific preparation. To ensure interchangeability in such circumstances, users may want to ensure equality of FUND function or determine these characteristics before use.

In this pdf format, you find a pdf of every Drug monograph like given below. Every pdf of the Monograph contain the following:-

DEFINITION
IDENTIFICATION
ASSAY

IMPURITIES
SPECIFIC TESTS
ADDITIONAL REQUIREMENTS

General Chapters

Every general chapter is assigned a number that appears in Ang brackets adjacent to the name of the chapter (e.g. chromatography)

General chapters can contain the following:

Description of tests and procedures for applications through monographs in dividual,
Specifications and Descriptions of practices & conditions for pharmaceutical compounding,
General information for interpretation of compensation requirements,
Description of general pharmaceutical storage, dispensing and packaging practice, or
General guidance for manufacturers of official substances or facial products.
When the general chapter is referenced in the monograph, the acceptance criteria can be presented after the large intestine.


Some chapters can function as an overview of Introduction to Exam or analytical techniques. They can refer other general chapters that contain techniques, procedure details, and, sometimes, acceptance criteria.


Indian Pharmacopoeia 2010 [ 3 Volume Set - PDF ]


The 6th edition of the Indian Pharmacopoeia 2010 is published by the Indian Pharmacopoeia Commission (IPC) in accordance with a plan and completed through the untiring efforts of its members, Secretariat and Laboratory over a period of about two years. It supersedes the 2007 edition but any monograph of the earlier edition that does not figure in this edition continues to be official as stipulated in the Second Schedule of the Drugs and Cosmetics Act, 1940. This edition would be effective from 1st September, 2010.

The Indian Pharmacopoeia 2010 is presented in three volumes. Volume I contains the Notices, Preface, the Structure of the IPC, Acknowledgements, Introduction, and the General Chapters. Volume II contains the General Notice, General Monographs on Dosage Forms, Monographs on drug substances, dosage forms and pharmaceutical aids (A to M). Volume III contains Monographs on drug substances, dosage forms and pharmaceutical aids (N to Z) followed by Monographs on Vaccines and Immunosera for Human use, Herbs and Herbal products, Blood and blood-related products, Biotechnology products and Veterinary products.

The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations. Standards for new drugs and drugs used under National Health Programmes are added and the drugs as well as their formulations not in use now a days are omitted from this edition. The number of monographs of Excipients, Anticancer drugs, Herbal products and Antiretroviral drugs have been increased in this edition. Monographs of Vaccines and Immunosera are also upgraded in view of development of latest technology in the field. A new chapter on Liposomal products and a monograph of Liposomal Amphotericin B injection is an added advantage in view of latest technology adopted for drug delivery. A chapter on NMR is incorporated in Appendices. The chapter on microbial contamination is also updated to a great extent to harmonise with prevailing international requirements.

Remington: The Science And Practice Of Pharmacy 21th Ed.

For over 100 years, Remington has been the definitive textbook and reference on the science and practice of pharmacy. This Twenty-First Edition keeps pace with recent changes in the pharmacy curriculum and professional pharmacy practice.

More than 95 new contributors and 5 new section editors provide fresh perspectives on the field. New chapters include pharmacogenomics, application of ethical principles to practice dilemmas, technology and automation, professional communication, medication errors, re-engineering pharmacy practice, management of special risk medicines, specialization in pharmacy practice, disease state management, emergency patient care, and wound care.

Download

Martindale: The Complete Drug Reference, 36th Edition

This book provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world. Each new drug licensed for use has its own potential benefits and adverse effects, and its own profile for dosage, administration and indications. Furthermore, manufacturers make regular changes to existing drug names and formulations, which can affect their interactions and safe usage. Health professionals require the correct answers and need to have confidence in the drugs information they use - but with medicines evolving at this rate, how can they be sure their knowledge is up to date? "Martindale" contains up to date information about more than 5,800 substances. Each and every entry is reviewed by our pharmaceutical editors to ensure health professionals have the most current data. Formulations change. Definitions change. Names change. But you can always trust "Martindale".

Download [Support us for this link by visiting ads on download page or by some donation]

USP NF 2009 (United States Pharmacopeia 32 / National Formulary 27)

The United States Pharmacopeia–National Formulary and its Supplements become official six months after being released to the public. The USP–NF, which is released on November 1 of each year, becomes official on May 1 of the following year.

This change was adopted to give users more time to bring their methods and procedures into compliance with new and revised USP–NF requirements.

The table below describes the new official dates. The 2008 USP31–NF26, and the Supplements and Interim Revision Announcements (IRAs) to that edition, will be official until May 1, 2009, at which time the USP32–NF27 becomes official.

European Pharmacopoeia 5th Ed. Main Volume 5.0, 2005

The purpose of the Pharmacopoeia is to promote public health, by the provision of recognised common standards for use by healthcare professionals and others concerned with the quality of medicines.

The monographs and other texts are designed to be appropriate to the needs of regulatory authorities, those engaged in the control of quality, and the manufacturers of starting materials and medicinal products.

The Japanese Pharmacopoeia Fifteenth Edition (JP XV)

This is the English version of the 15th edition of the "Japanese Pharmacopoeia". It provides the official Japanese standard for the description and quality of drug substances and products. It contains over 1,300 articles regarding: general rules for preparations; processes and apparatus; monographs on drugs; and infrared reference spectra and ultraviolet-visible reference spectra.

Official Monographs provides 1483 articles, including 102 articles newly added and 8 articles deleted. Comprises the following items in order: The Ministry of Health, Labour and Welfare Ministerial Notification; Contents; Preface; General Notices; General Rules for Crude Drugs; General Rules for Preparations; General Tests, Processes and Apparatus; Official Monographs, including Monographs for Crude Drugs; Infrared Reference Spectra; Ultraviolet-visual Reference Spectra; General Information; Atomic Weight Table (2004) and Standard Atomic Weights 2004 as Appendix ; and Cumulative Index (English, Latin and Japanese titles).

British National Formulary 57: March 2009

This is the authoritative guide to prescribing, dispensing and administering medicines for all health care professionals. Nobody working in health care can afford to be without the latest edition of "BNF". Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from all credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, administering, and monitoring medicines. Not only does the "BNF" include the widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects, dosage and relative costs. This allows treatment to be tailored to the individual needs of each patient. Updated in print every six months by an expert team of pharmacists, with guidance and validation from a network of leading clinicians, and oversight by a Joint Formulary Committee with representatives from all spheres of clinical practice. "The BNF" reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited in Parliaments and courts as a source of authority.

The Veterinary Pharmacopoeia, Materia Medica, and Therapeutics

The Veterinary Pharmacopoeia, Materia Medica, and Therapeutics,
By George Gresswell

British Pharmacopoeia 2009

"The British Pharmacopoeia" ("BP") 2009 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy.The "BP" comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. Detailed information and guidance on various aspects of current pharmacopoeial policy and practice are provided in the Supplementary Chapters of the "BP".The "BP" is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition comprises a five-volume boxed set containing the "BP" in four volumes and the "BP" (Veterinary) volume, plus single user access to the "BP" Online, the dedicated BP website. The online format is easy to network, allowing access for a specified number of users or across an entire organisation site.Following registration - using the ID code supplied with the hard copy - customers will be granted a single user licence to access BP on-line and will have the option to receive the CD-ROM, which contains the whole of the current "British Pharmacopoeia".It is effective as of 1 January 2009. It includes: a significant number of new UK monographs; all "European Pharmacopoeia 6th Edition" material up to and including "Supplement 6.2" integrated into the text of "BP 2009"; new and revised monographs for Complementary, Herbal and Homoeopathic medicines with their own section in Volume III; and networking with full technical support from TSO, the publisher of the "BP". The on-line version delivers the complete text of the "British Pharmacopoeia and European Pharmacopoeia" standards to your PC. The new features include an alphabetical index, user-friendly search interface design, and a facility to create a 'My BP' section." British Pharmacopoeia 2009" eBook - "The complete British Pharmacopoeia 2009" is now available exclusively to "BP 2009" purchasers in an innovative new format. The eBook is greatly suited to this large reference text making the information contained within it available to all of those who wish to access it on the move and away from their desks.British Pharmacopoeia 2009 Concurrent Licence (Online) - "The British Pharmacopoeia" is available as a network licence which can be used on a concurrent user basis. It allows a designated number of staff simultaneous access to the online version of the "British Pharmacopoeia 2009". Once set up, your workforce can then start using the BP at their convenience.

[Please Support us for these links by visiting ads on download page]

A to Z Drug Facts: Published by Facts and Comparisons

This compact, portable, alphabetically organized drug reference provides quick access to current, reliable information on more than 4,500 commonly prescribed medications. Each drug monograph is divided into pharmacological and patient care considerations, and includes action, indications, contraindications, route/dosage, interactions, lab test interferences, adverse reactions, precautions/warnings, administration/storage, assessment/interventions, and patient/family education. Icons and a second color are used to help readers quickly locate the information they are looking for. A color identification section enables readers to identify drugs by appearance. Coverage includes the newest FDA approvals, investigational and orphan drugs, and indications for labeled, unlabeled, and orphan uses.

AHFS Drug Information

Annual reference provides a comprehensive evidence-based collection of more than 1,000 drug monographs. Each listing includes FDA-approved uses, evidence-based coverage of off-label uses, drug interactions, cautions, toxicity, dosage recommendations, coverage of pharmacology and pharmacokinetics, and more. For pharmacists and other healthcare professionals. Softcover.

Download

The Pharmacopoeia of the United States of America: Facsimile of the First Edition (1820)

The Pharmacopoeia of the United States of America: (The United States Pharmacopoeia). By General Medical Convention, United States Pharmacopeial Convention Committee of Revision, United States Pharmacopœial Convention, General Convention for the Formation of the American Pharmacopoeia, National Convention for Revising the Pharmacopoeia Published by United States Pharmacopoeial Convention, Inc., 1820-1975., 1820

Download

European Pharmacopoeia, 4th edition

The European Pharmacopoeia is a single reference work for the quality control of medicines in Europe. Several legal texts make the European Pharmacopoeia mandatory:A Convention on the Elaboration of a European Pharmacopoeia ratified in 2003 by 31 European countries and the European Union; European Union directives 2001/83/EC and 2001/82/EC,on medicines for human use and for veterinary use, respectively, maintain the mandatory character of European Pharmacopoeia specifications on medicines as regards their qualitative and quantitative composition and the tests to be carried out on these medicines, the raw materials used in production and the intermediates of synthesis. All producers of medicines or substances for pharmaceutical use therefore must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe. The texts of the European Pharmacopoeia are legally binding and compliance is enforced by the administrative or juridical authorities. The national authorities of the member states are bound to apply them if necessary replacing any national monograph on the same subject.

The 4th Edition consists of an initial volume 2002 (4.0) and a collection of 8 non-cumulative supplements (4.1) published three times a year following the decisions of each session of the European Pharmacopoeia Commission. With supplement 4.6, the 4th Edition comprises 1750 specific monographs, 285 general methods illustrated by figures or chromatograms and 2140 reagents. Every 4 months a new volume enters into force.

Download

British National Formulary 56

Compiled with the advice of clinical experts, the British National Formulary (BNF) provides up-to-date guidance on prescribing, dispensing and administering medicines.

The BNF details medicines prescribed in the UK, with special reference to their uses, cautions, contra-indications, side-effects, dosage and relative costs.

Updated every six months, the BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. It is intended for use by prescribers, pharmacists and other healthcare professionals.

  • Designed for rapid reference
  • Authoritative, impartial and, where available, evidence-based advice on prescribing, dispensing and administering medicines
  • Updated twice a year to reflect promptly changes in product availability as well as emerging safety concerns and shifts in clinical practice

Herb Navigator-Materia Medica

User friendly revolutionary program that will allow you quickly and easily improve the accuracy of your clinical observations, diag- nosis and herbal prescriptions.

With a few clicks of the mouse, you can quickly and easily see more clearly the possibilities and best use of interconnected formulas, conditions, and actions.

  • Over 140 herbs and over 400 specific ailments are referenced
  • Search by indication
  • Unique search by multiple actions
  • The program offers you the ability to add your own data.
  • Preparation methods are given for each herb
  • Adult dosage ranges for all appropriate preparations are given

Download

The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals


The Merck Index is a one-volume encyclopedia of chemicals, drugs and biologicals that contains more than 10,000 monographs. Each monograph in this authoritative reference source is a concise description of a single substance or a small group of closely related compounds.

Compounds included:

• human and veterinary drugs

• biotech drugs and monoclonal antibodies

• substances used for medical imaging

• biologicals and natural products

• plants and traditional medicines

• nutraceuticals and cosmeceuticals

• agriculturals, pesticides and herbicides

• Organic chemicals used in research

• Food additives and supplements

• dyes, colors and indicators

• environmentally significant substances

Information provided:

• chemical, common and generic names

• Over 15,000 trademarks and associated companies

• CAS Registry Numbers for over 12,000 compounds

• Over 8,500 chemical structures

• molecular formulae, weights and percentage composition

• capsule statements identifying compound classes and scientific significance

• scientific and patent literature references

• physical and toxicity data

• therapeutic and commercial uses

• caution and hazard information

In addition, there are more than 700 new and completely revised monographs, thousands of new references, trademarks and uses added to existing monographs. Now includes a companion CD-ROM which features 989 monographs no longer available in print, organic name reactions, supplemental tables and a new user interface for user-friendly searching.

Features of the CD:

  • Searchable by keywords, references, and numerical properties
  • Search the complete contents of the 14th edition, plus nearly a thousand monographs archived from previous editions
  • Comes with a free one-year subscription to the Merck Index Internet Edition
  • Windows-compatible CD powered by CambridgeSoft's ChemFinder
  • Extensively revised supplemental tables now including acronyms, vaccines, and physical constants
  • More than 70 pages of hard to find information in one easy-to-use place
Download (Updated)

The International Pharmacopoeia, Third Edition

Presents an historical account of the Pharmacopoeia and describes methods and procedures for the quality control of pharmaceutical substances and dosage forms, including a special section on quality control of anti-malarials.